Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis

Background Nasal obstruction is a common complaint in patients with sleep‐disordered breathing and obstructive sleep apnea (OSA). Although topical nasal treatments (TNTs) have been shown to reduce nasal resistance and improve nasal obstruction, there is conflicting evidence regarding the role of TNT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International forum of allergy & rhinology 2021-02, Vol.11 (2), p.153-161
Hauptverfasser: Nguyen, Dang‐Khoa, Liang, Jonathan, Durr, Megan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 161
container_issue 2
container_start_page 153
container_title International forum of allergy & rhinology
container_volume 11
creator Nguyen, Dang‐Khoa
Liang, Jonathan
Durr, Megan
description Background Nasal obstruction is a common complaint in patients with sleep‐disordered breathing and obstructive sleep apnea (OSA). Although topical nasal treatments (TNTs) have been shown to reduce nasal resistance and improve nasal obstruction, there is conflicting evidence regarding the role of TNTs in adult OSA. In this systematic review and meta‐analysis we aim to evaluate the role of TNTs in adults with OSA. Data sources used included PubMed, Ovid MEDLINE, and Cochrane Central, from January 2001 to July 2019. Methods Inclusion criteria were English‐language studies containing original data on TNTs in adults (≥18 years) with OSA (apnea‐hypopnea index [AHI] ≥5). Exclusion criteria were case reports, studies without outcome measures, and concurrent non‐TNT treatment for OSA. Two investigators independently reviewed all articles and performed quality assessment using validated tools. Meta‐analysis and quality assessment were performed. Results Of the 2180 s identified, 8 studies met inclusion criteria. TNTs included decongestants (4 of 8 studies), corticosteroids (3 of 8), and antihistamines (1 of 8). Outcome measures included AHI (8 of 8), respiratory distress index (RDI; 1 of 8), oxygen‐desaturation index (ODI; 3 of 8), minimum SaO2 (MinSaO2; 4 of 8), nasal resistance (4 of 8), endoscopic sinus surgery (4 of 8 studies) and standardized rhinoconjunctivitis quality of life questionnaire scores (1 of 8 studies). Qualitatively, all studies showed trends toward improving objective and subjective measures of OSA, although the significance of these improvements varied across studies. A meta‐analysis was performed in 5 studies, but TNTs did not reveal a significant change in AHI (p > 0.05). Conclusion TNTs may improve minimum oxygen saturation, ODI, RDI, and subjective/quality‐of‐life measures. Allergic patients may have more improvement in OSA measures compared with nonallergic patients. Future studies are indicated to accurately determine the efficacy of TNTs.
doi_str_mv 10.1002/alr.22658
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2427520331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2491775403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4198-62f9c79f9137fd2625fcabc5d6f8d7eaf396be9e237ef05d13fe38d3b04395db3</originalsourceid><addsrcrecordid>eNp10c1KHTEYBuBQLCqnLryBEuhGF0fzM5lMuhOprXBAEF0PmeQLRDI_TTJHZtdL6DX2SowedVEwi-QjPLyEvAgdU3JGCWHnOsQzxmrRfEKHjFRsXaum2nufZX2AjlJ6IGUJKgSV--iAM0k5ratDlO7GyRsd8KBT2XMEnXsYMgbnyr1Z8DhgbeeQ8dilHGeT_RZwCgAT1tMAGifYQvR5-Y7LvKQMvc7e4AhbD49YDxb3kPW_P3_1oMOSfPqCPjsdEhy9nit0f_Xj7vLXenPz8_ryYrM2FVXNumZOGamcolw6y2omnNGdEbZ2jZWgHVd1BwoYl-CIsJQ74I3lHam4ErbjK3Syy53i-HuGlNveJwMh6AHGObWsYlIwwjkt9Nt_9GGcY3nvs1JUSlEVt0KnO2XimFIE107R9zouLSXtcxltKaN9KaPYr6-Jc9eDfZdvX1_A-Q48-gDLx0ntxeZ2F_kEZSmVxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491775403</pqid></control><display><type>article</type><title>Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis</title><source>Wiley Online Library All Journals</source><creator>Nguyen, Dang‐Khoa ; Liang, Jonathan ; Durr, Megan</creator><creatorcontrib>Nguyen, Dang‐Khoa ; Liang, Jonathan ; Durr, Megan</creatorcontrib><description>Background Nasal obstruction is a common complaint in patients with sleep‐disordered breathing and obstructive sleep apnea (OSA). Although topical nasal treatments (TNTs) have been shown to reduce nasal resistance and improve nasal obstruction, there is conflicting evidence regarding the role of TNTs in adult OSA. In this systematic review and meta‐analysis we aim to evaluate the role of TNTs in adults with OSA. Data sources used included PubMed, Ovid MEDLINE, and Cochrane Central, from January 2001 to July 2019. Methods Inclusion criteria were English‐language studies containing original data on TNTs in adults (≥18 years) with OSA (apnea‐hypopnea index [AHI] ≥5). Exclusion criteria were case reports, studies without outcome measures, and concurrent non‐TNT treatment for OSA. Two investigators independently reviewed all articles and performed quality assessment using validated tools. Meta‐analysis and quality assessment were performed. Results Of the 2180 s identified, 8 studies met inclusion criteria. TNTs included decongestants (4 of 8 studies), corticosteroids (3 of 8), and antihistamines (1 of 8). Outcome measures included AHI (8 of 8), respiratory distress index (RDI; 1 of 8), oxygen‐desaturation index (ODI; 3 of 8), minimum SaO2 (MinSaO2; 4 of 8), nasal resistance (4 of 8), endoscopic sinus surgery (4 of 8 studies) and standardized rhinoconjunctivitis quality of life questionnaire scores (1 of 8 studies). Qualitatively, all studies showed trends toward improving objective and subjective measures of OSA, although the significance of these improvements varied across studies. A meta‐analysis was performed in 5 studies, but TNTs did not reveal a significant change in AHI (p &gt; 0.05). Conclusion TNTs may improve minimum oxygen saturation, ODI, RDI, and subjective/quality‐of‐life measures. Allergic patients may have more improvement in OSA measures compared with nonallergic patients. Future studies are indicated to accurately determine the efficacy of TNTs.</description><identifier>ISSN: 2042-6976</identifier><identifier>EISSN: 2042-6984</identifier><identifier>DOI: 10.1002/alr.22658</identifier><identifier>PMID: 32713164</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adults ; allergic rhinitis ; Antihistamines ; Apnea ; Case reports ; corticosteroid use ; Corticosteroids ; Meta-analysis ; Oxygen ; Patients ; Quality control ; Quality of life ; Rhinoconjunctivitis ; Sleep ; Sleep apnea ; Sleep disorders ; steroid therapy ; Surgery ; Systematic review ; therapeutics</subject><ispartof>International forum of allergy &amp; rhinology, 2021-02, Vol.11 (2), p.153-161</ispartof><rights>2020 ARS‐AAOA, LLC</rights><rights>2020 ARS-AAOA, LLC.</rights><rights>2021 ARS‐AAOA, LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4198-62f9c79f9137fd2625fcabc5d6f8d7eaf396be9e237ef05d13fe38d3b04395db3</citedby><cites>FETCH-LOGICAL-c4198-62f9c79f9137fd2625fcabc5d6f8d7eaf396be9e237ef05d13fe38d3b04395db3</cites><orcidid>0000-0002-8673-523X ; 0000-0003-1084-8702</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Falr.22658$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Falr.22658$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32713164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Dang‐Khoa</creatorcontrib><creatorcontrib>Liang, Jonathan</creatorcontrib><creatorcontrib>Durr, Megan</creatorcontrib><title>Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis</title><title>International forum of allergy &amp; rhinology</title><addtitle>Int Forum Allergy Rhinol</addtitle><description>Background Nasal obstruction is a common complaint in patients with sleep‐disordered breathing and obstructive sleep apnea (OSA). Although topical nasal treatments (TNTs) have been shown to reduce nasal resistance and improve nasal obstruction, there is conflicting evidence regarding the role of TNTs in adult OSA. In this systematic review and meta‐analysis we aim to evaluate the role of TNTs in adults with OSA. Data sources used included PubMed, Ovid MEDLINE, and Cochrane Central, from January 2001 to July 2019. Methods Inclusion criteria were English‐language studies containing original data on TNTs in adults (≥18 years) with OSA (apnea‐hypopnea index [AHI] ≥5). Exclusion criteria were case reports, studies without outcome measures, and concurrent non‐TNT treatment for OSA. Two investigators independently reviewed all articles and performed quality assessment using validated tools. Meta‐analysis and quality assessment were performed. Results Of the 2180 s identified, 8 studies met inclusion criteria. TNTs included decongestants (4 of 8 studies), corticosteroids (3 of 8), and antihistamines (1 of 8). Outcome measures included AHI (8 of 8), respiratory distress index (RDI; 1 of 8), oxygen‐desaturation index (ODI; 3 of 8), minimum SaO2 (MinSaO2; 4 of 8), nasal resistance (4 of 8), endoscopic sinus surgery (4 of 8 studies) and standardized rhinoconjunctivitis quality of life questionnaire scores (1 of 8 studies). Qualitatively, all studies showed trends toward improving objective and subjective measures of OSA, although the significance of these improvements varied across studies. A meta‐analysis was performed in 5 studies, but TNTs did not reveal a significant change in AHI (p &gt; 0.05). Conclusion TNTs may improve minimum oxygen saturation, ODI, RDI, and subjective/quality‐of‐life measures. Allergic patients may have more improvement in OSA measures compared with nonallergic patients. Future studies are indicated to accurately determine the efficacy of TNTs.</description><subject>Adults</subject><subject>allergic rhinitis</subject><subject>Antihistamines</subject><subject>Apnea</subject><subject>Case reports</subject><subject>corticosteroid use</subject><subject>Corticosteroids</subject><subject>Meta-analysis</subject><subject>Oxygen</subject><subject>Patients</subject><subject>Quality control</subject><subject>Quality of life</subject><subject>Rhinoconjunctivitis</subject><subject>Sleep</subject><subject>Sleep apnea</subject><subject>Sleep disorders</subject><subject>steroid therapy</subject><subject>Surgery</subject><subject>Systematic review</subject><subject>therapeutics</subject><issn>2042-6976</issn><issn>2042-6984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp10c1KHTEYBuBQLCqnLryBEuhGF0fzM5lMuhOprXBAEF0PmeQLRDI_TTJHZtdL6DX2SowedVEwi-QjPLyEvAgdU3JGCWHnOsQzxmrRfEKHjFRsXaum2nufZX2AjlJ6IGUJKgSV--iAM0k5ratDlO7GyRsd8KBT2XMEnXsYMgbnyr1Z8DhgbeeQ8dilHGeT_RZwCgAT1tMAGifYQvR5-Y7LvKQMvc7e4AhbD49YDxb3kPW_P3_1oMOSfPqCPjsdEhy9nit0f_Xj7vLXenPz8_ryYrM2FVXNumZOGamcolw6y2omnNGdEbZ2jZWgHVd1BwoYl-CIsJQ74I3lHam4ErbjK3Syy53i-HuGlNveJwMh6AHGObWsYlIwwjkt9Nt_9GGcY3nvs1JUSlEVt0KnO2XimFIE107R9zouLSXtcxltKaN9KaPYr6-Jc9eDfZdvX1_A-Q48-gDLx0ntxeZ2F_kEZSmVxg</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Nguyen, Dang‐Khoa</creator><creator>Liang, Jonathan</creator><creator>Durr, Megan</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8673-523X</orcidid><orcidid>https://orcid.org/0000-0003-1084-8702</orcidid></search><sort><creationdate>202102</creationdate><title>Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis</title><author>Nguyen, Dang‐Khoa ; Liang, Jonathan ; Durr, Megan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4198-62f9c79f9137fd2625fcabc5d6f8d7eaf396be9e237ef05d13fe38d3b04395db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adults</topic><topic>allergic rhinitis</topic><topic>Antihistamines</topic><topic>Apnea</topic><topic>Case reports</topic><topic>corticosteroid use</topic><topic>Corticosteroids</topic><topic>Meta-analysis</topic><topic>Oxygen</topic><topic>Patients</topic><topic>Quality control</topic><topic>Quality of life</topic><topic>Rhinoconjunctivitis</topic><topic>Sleep</topic><topic>Sleep apnea</topic><topic>Sleep disorders</topic><topic>steroid therapy</topic><topic>Surgery</topic><topic>Systematic review</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Dang‐Khoa</creatorcontrib><creatorcontrib>Liang, Jonathan</creatorcontrib><creatorcontrib>Durr, Megan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International forum of allergy &amp; rhinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Dang‐Khoa</au><au>Liang, Jonathan</au><au>Durr, Megan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis</atitle><jtitle>International forum of allergy &amp; rhinology</jtitle><addtitle>Int Forum Allergy Rhinol</addtitle><date>2021-02</date><risdate>2021</risdate><volume>11</volume><issue>2</issue><spage>153</spage><epage>161</epage><pages>153-161</pages><issn>2042-6976</issn><eissn>2042-6984</eissn><abstract>Background Nasal obstruction is a common complaint in patients with sleep‐disordered breathing and obstructive sleep apnea (OSA). Although topical nasal treatments (TNTs) have been shown to reduce nasal resistance and improve nasal obstruction, there is conflicting evidence regarding the role of TNTs in adult OSA. In this systematic review and meta‐analysis we aim to evaluate the role of TNTs in adults with OSA. Data sources used included PubMed, Ovid MEDLINE, and Cochrane Central, from January 2001 to July 2019. Methods Inclusion criteria were English‐language studies containing original data on TNTs in adults (≥18 years) with OSA (apnea‐hypopnea index [AHI] ≥5). Exclusion criteria were case reports, studies without outcome measures, and concurrent non‐TNT treatment for OSA. Two investigators independently reviewed all articles and performed quality assessment using validated tools. Meta‐analysis and quality assessment were performed. Results Of the 2180 s identified, 8 studies met inclusion criteria. TNTs included decongestants (4 of 8 studies), corticosteroids (3 of 8), and antihistamines (1 of 8). Outcome measures included AHI (8 of 8), respiratory distress index (RDI; 1 of 8), oxygen‐desaturation index (ODI; 3 of 8), minimum SaO2 (MinSaO2; 4 of 8), nasal resistance (4 of 8), endoscopic sinus surgery (4 of 8 studies) and standardized rhinoconjunctivitis quality of life questionnaire scores (1 of 8 studies). Qualitatively, all studies showed trends toward improving objective and subjective measures of OSA, although the significance of these improvements varied across studies. A meta‐analysis was performed in 5 studies, but TNTs did not reveal a significant change in AHI (p &gt; 0.05). Conclusion TNTs may improve minimum oxygen saturation, ODI, RDI, and subjective/quality‐of‐life measures. Allergic patients may have more improvement in OSA measures compared with nonallergic patients. Future studies are indicated to accurately determine the efficacy of TNTs.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32713164</pmid><doi>10.1002/alr.22658</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8673-523X</orcidid><orcidid>https://orcid.org/0000-0003-1084-8702</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2042-6976
ispartof International forum of allergy & rhinology, 2021-02, Vol.11 (2), p.153-161
issn 2042-6976
2042-6984
language eng
recordid cdi_proquest_miscellaneous_2427520331
source Wiley Online Library All Journals
subjects Adults
allergic rhinitis
Antihistamines
Apnea
Case reports
corticosteroid use
Corticosteroids
Meta-analysis
Oxygen
Patients
Quality control
Quality of life
Rhinoconjunctivitis
Sleep
Sleep apnea
Sleep disorders
steroid therapy
Surgery
Systematic review
therapeutics
title Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A37%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topical%20nasal%20treatment%20efficacy%20on%20adult%20obstructive%20sleep%20apnea%20severity:%20a%20systematic%20review%20and%20meta%E2%80%90analysis&rft.jtitle=International%20forum%20of%20allergy%20&%20rhinology&rft.au=Nguyen,%20Dang%E2%80%90Khoa&rft.date=2021-02&rft.volume=11&rft.issue=2&rft.spage=153&rft.epage=161&rft.pages=153-161&rft.issn=2042-6976&rft.eissn=2042-6984&rft_id=info:doi/10.1002/alr.22658&rft_dat=%3Cproquest_cross%3E2491775403%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2491775403&rft_id=info:pmid/32713164&rfr_iscdi=true